Follistatin Mitigates Atherosclerosis Through Activation of Arginine Metabolism and Adipose Browning
Cells · 02.07.2026 · 15 (13) · 1205
DOI: 10.3390/cells15131205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 02.07.2026. Verfasst von Golnaz Dirakvand und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, California State University, Dominguez Hills, Los Angeles, CA 90747, USA. Hauptthemen laut MEDLINE: Adipose Tissue, Brown, Atherosclerosis, Arginine, Follistatin. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charles R. Drew University of Medicine and Science, NIGMS NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Follistatin (FST) binds to and neutralizes members of the transforming growth factor-beta (TGF-β) superfamily, thereby regulating diverse physiological processes, including regulation of skeletal muscle, adipose, and bone homeostasis. FST also promotes adipose browning and enhances energy metabolism, leading to improved plasma lipid profiles and metabolic health in mice. Given the emerging association between brown adipose tissue (BAT) activation and reduced atherosclerosis, we investigated the anti-atherogenic potential of FST. Transcriptomic and metabolomic analyses of the Hybrid Mouse Diversity Panel (HMDP) revealed that Fst expression was negatively correlated with aortic lesion area and positively correlated with the expression of multiple adipose browning-associated genes. Adeno-associated viral delivery of Fst (AAV1-FST344) in Ldlr−/− mice significantly reduced aortic lesion area, improved plasma lipid profiles, and decreased expression of adhesion (VCAM1) and inflammatory (iNOS, TNF-α) markers in white adipose tissue (WAT), liver, and heart. Fst gene delivery also markedly increased uncoupling protein 1 (UCP1) expression in WAT, consistent with WAT browning. Integrated correlation analyses of Fst expression with tissue metabolites, together with plasma metabolite–lesion associations identified in the HMDP, implicated the arginase 1 (Arg1)-mediated metabolic pathway as a key regulator of atherogenesis. Consistent with these findings, Arg1 expression was significantly elevated in WAT, liver, and heart of AAV1-FST344-treated mice and in wild-type versus Fst-knockout mouse embryonic fibroblasts (MEFs). Immunostaining localized Arg1 predominantly to CD68+ macrophages in heart and liver. Given recent evidence identifying Arg1 as a novel mediator of efferocytosis, these findings suggest that Arg1 may promote macrophage metabolic reprogramming and resolution of inflammation by enhancing the clearance of apoptotic cells. Furthermore, Fst gene delivery increased the expression of fibroblast growth factor 21 (Fgf21) and adiponectin (AdipoQ) in WAT. Collectively, these findings identify Fst as a novel anti-atherogenic regulator that protects against vascular disease by promoting adipose browning, improving lipid metabolism, and activating Arg1-mediated metabolic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, California State University, Dominguez Hills, Los Angeles, CA 90747, USA.
- Division of Endocrinology and Metabolism, College of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90747, USA.
- Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90747, USA.
- Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90747, USA.
ORCID-Profile: Brian Villa, Srinivasa T Reddy, Rajan Singh
Förderung
- Charles R. Drew University of Medicine and Science
- NIGMS NIH HHS
- NIA NIH HHS
- NIMHD NIH HHS
- NIEHS NIH HHS
- National Institute of Health
- TRDRP
- Charles R Drew University of Medicine and Science
Zitieren
APA
Dirakvand, G., Pervin, S., Villa, B., Le, C., Yohanna, K., Grijalva, V., Chattopadhyay, A., Sinha, S. K., Reddy, S. T., & Singh, R. (2026). Follistatin Mitigates Atherosclerosis Through Activation of Arginine Metabolism and Adipose Browning. Cells, 15(13), 1205. https://doi.org/10.3390/cells15131205
Vancouver
Dirakvand G, Pervin S, Villa B, Le C, Yohanna K, Grijalva V, et al. Follistatin Mitigates Atherosclerosis Through Activation of Arginine Metabolism and Adipose Browning. Cells. 2026;15(13):1205. doi:10.3390/cells15131205
BibTeX
@article{Dirakvand2026,
author = {Dirakvand, Golnaz and Pervin, Shehla and Villa, Brian and Le, Christy and Yohanna, Kristine and Grijalva, Victor and Chattopadhyay, Arnab and Sinha, Satyesh K and Reddy, Srinivasa T and Singh, Rajan},
title = {Follistatin Mitigates Atherosclerosis Through Activation of Arginine Metabolism and Adipose Browning},
journal = {Cells},
year = {2026},
volume = {15},
number = {13},
pages = {1205},
doi = {10.3390/cells15131205}
}
EUVIMED